Page last updated: 2024-09-03

t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and leukotriene c4

t-butyloxycarbonyl-methionyl-leucyl-phenylalanine has been researched along with leukotriene c4 in 1 studies

Compound Research Comparison

Studies
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Trials
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Recent Studies (post-2010)
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Studies
(leukotriene c4)
Trials
(leukotriene c4)
Recent Studies (post-2010) (leukotriene c4)
22041,26040193

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciccarelli, A; Cirillo, R; de Crescenzo, G; de Paulis, A; Marone, G; Patella, V1

Other Studies

1 other study(ies) available for t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and leukotriene c4

ArticleYear
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    The Journal of allergy and clinical immunology, 1996, Volume: 98, Issue:1

    Topics: Basophils; Binding, Competitive; Bryostatins; Chemokine CCL2; Chemokine CCL5; Complement C5a; Cyclosporine; Histamine Release; Humans; Interleukin-1; Interleukin-8; Kinetics; Lactones; Leukotriene C4; Macrolides; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Platelet Activating Factor; Protein Binding; Tetradecanoylphorbol Acetate

1996